C.R. Bard said it has closed on the acquisition of California-based SenoRx and folded the company’s operations into its peripheral vascular division. The acquisition, which was initially ...

C.R. Bard (NYSE: BCR)stock soared 19.5% higher on Monday after medical supply giantBecton, Dickinson(NYSE: BDX)announced it's acquiring the company for about $24 billion in cash and stock. Becton ...

Looking at the universe of stocks we cover at Dividend Channel, on 4/26/12, C.R. Bard, Inc. (NYSE: BCR) will trade ex-dividend, for its quarterly dividend of $0.19, payable on 5/11/12. As a ...

C.R. Bard says acquiring Medafor gives it the opportunity to expand in the global market for surgical hemostats, which is over $1.4 billion. C.R. Bard expects the transaction to add approximately ...

C.R. Bard, Inc. faces more than 25,000 lawsuits in state and federal courts, with the first trial in the federal multidistrict litigation (MDL) fully underway, as reported by medtruth.com and Reuters.

C.R. Bard announced that it has entered into a definitive agreement to acquire privately-held Medafor. C.R. Bard will pay some $200 million for the developer and supplier of plant based hemostatic ...

C.R. Bard Inc. was ordered to pay $35 million in punitive damages to a woman who blamed her injuries on the company’s vaginal mesh inserts in the medical supplier’s first case over the ...

Investors in C.R. Bard, Inc. (NYSE: BCR) saw new options begin trading today, for the July 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...

C.R. Bard (NYSE:BCR) has been upgraded by TheStreet Ratings from a hold to buy.

LOS ANGELES (MarketWatch) -- Shares of C.R. Bard vaulted by more than 9% at one point Thursday, after the medical products maker reported earnings that beat expectations, topped off with a ...

COLONIE — Latham's AngioDynamics is alleging that a major competitor in the medical device market, C.R. Bard, is violating anti-trust laws in the sale of its catheters. In a lawsuit filed in U.S ...

C.R. Bard, which has its largest domestic manufacturing plant in Queensbury, Wednesday reported a slight decline in year-over-year first-quarter net income. But the medical instruments maker ...